Ayad K. Ali, PhD

BeOne Medicines Ltd

Poster(s):

• 1401 - Risk of Second Primary Malignancies in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving First-line Therapy: A Real-World Study